$0 Co-Pay Program

Rubraca is available at $0 co-pay to 100% of commercially insured patients, regardless of income.


Text-based support

The Clovis4YOU text message support program is a personalized patient program with medication reminders, daily tips, emotional support, and more that can help you throughout treatment.


Share Your Story

You can make a difference for yourself and others by sharing your experiences and perspective.

Focus on your care, and find the support you need

Rubraca Connections is here to support you

Rubraca Connections is a personalized support program with live dedicated Access Specialists to answer your questions about starting, affording, and continuing your Rubraca

Starting Rubraca

Starting Rubraca tablets

Rubraca is not available at your local drugstore, so Rubraca Connections can help you find out which pharmacy works with your insurance company.

  • You can receive Rubraca from one of 4 specialty pharmacies that can call you with more information and mail your treatment to you
  • Your doctor’s office may have a pharmacy that dispenses Rubraca. If so, ask your doctor about your Rubraca delivery
Affording Rubraca

Affording Rubraca

Regardless of your income or insurance type, Rubraca Connections will work with you to help you get the support you need.

If you have private or commercial insurance

Rubraca Connections $0 Co-Pay Program

If you qualify for the Rubraca Connections $0 Co-Pay Program, 100% of your out-of-pocket drug costs are covered, which means you pay $0 for Rubraca. You can receive support of up to $30,000 per calendar year.


If you have government insurance (Medicare, Medicaid, and VA/DoD*)

Independent co-pay foundations

If you have government insurance, you may be able to get help with out-of-pocket drug costs from an independent co-pay foundation. Your Rubraca Connections Access Specialist can give you a list of potential foundations.


If you have no insurance, or Rubraca is not covered

Rubraca Connections Patient Assistance Program

If you have no health insurance or your health insurance does not cover Rubraca, you may be eligible for this program. Your Rubraca Connections Access Specialist will let you know if you qualify based on your household income and diagnosis.

Continuing Rubraca

Continuing Rubraca

As you work with your doctor on a care and treatment plan, there may be other programs and personal support that Rubraca Connections can help you find.

  • If you’re getting Rubraca from a specialty pharmacy, you may receive 24/7 support for questions about dosing, side effects, and general information
  • If you get Rubraca through the pharmacy at your doctor’s office, contact the office to find out about support they may have for side effect management

*D0D=Department of Defense; VA=Veterans Affairs.

24/7 support is only offered by participating specialty pharmacies.

Gen image
Rubraca Connections can support you in getting Rubraca and help you in navigating financial assistance. For more information, call 1-844-779-7707, Monday through Friday, 8 am to 8 pm ET, or visit www.RubracaConnections.com

What is Rubraca used for?

Rubraca® (rucaparib) tablets are a prescription medicine used in adults for the treatment of castration-resistant prostate cancer (prostate cancer that no longer responds to medical or surgical treatment that lowers testosterone):

  • that has spread to other parts of the body, and
  • has a certain type of inherited (germline) or acquired (somatic) abnormal BRCA gene, and you have been treated with certain medicines for your cancer.

Rubraca was approved based on response rate and how long patients’ responses lasted. There are ongoing studies to confirm the clinical benefit of Rubraca. Your healthcare provider will perform a test to make sure Rubraca is right for you.

It is not known if Rubraca is safe and effective in children.

What Warnings should I know about Rubraca?

Rubraca tablets may cause serious side effects including bone marrow problems called Myelodysplastic Syndrome (MDS) or a type of cancer of the blood called Acute Myeloid Leukemia (AML). Some people who have ovarian cancer and who have received previous treatment with chemotherapy or certain other medicines for their cancer have developed MDS or AML during or after treatment with Rubraca, although MDS or AML was not observed in men with prostate cancer during the clinical study. MDS or AML may lead to death. If you develop MDS or AML, your healthcare provider will stop treatment with Rubraca.

If you are a male with a female partner who is pregnant or able to become pregnant, effective birth control should be used during treatment and for 3 months after the last dose of Rubraca. Do not donate sperm during use and for 3 months after the last dose of Rubraca.

What other important information should I know about Rubraca?

Your healthcare provider will do blood tests before, and every month during treatment with Rubraca to monitor your blood cell counts. Weekly blood tests will be performed if you have low blood cell counts for a long time. Your healthcare provider may stop treatment with Rubraca until your blood cell counts improve.

Avoid spending time in sunlight while on Rubraca since your skin may become more sensitive to the sun and may sunburn more easily. You should wear a hat and clothes that cover your skin and use sunscreen to help protect against sunburn if you have to be in the sunlight.

What are the side effects of Rubraca?

The most common side effects for men in Rubraca clinical studies were weakness/fatigue, nausea, decreased red blood cell count, changes in liver function tests, decreased appetite, constipation, rash, decreased platelet count, vomiting, and diarrhea.

What other medications might interact with Rubraca?

Rubraca can increase the amounts of other medications you may be taking which can increase the risk of side effects. Tell your healthcare provider about all of your medical conditions and all medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

You may report side effects to the FDA at 1‑800‑FDA‑1088 or www.fda.gov/medwatch. You may also report side effects to Clovis Oncology, Inc. at 1‑415‑409‑7220 (US toll) or 1‑844‑CLVS‑ONC (1‑844‑258‑7662; US toll-free).

Please see full Prescribing Information, including Patient Information, for additional Important Safety Information.